APA (7th ed.) Citation

Ting-Chun Liu, Chien-Ning Hsu, Wen-Chin Lee, Shih-Wei Wang, Chiang-Chi Huang, Yueh-Ting Lee, . . . Lung-Chih Li. (2023). Denosumab Is Superior to Raloxifene in Lowering Risks of Mortality and Ischemic Stroke in Osteoporotic Women. MDPI AG.

Chicago Style (17th ed.) Citation

Ting-Chun Liu, Chien-Ning Hsu, Wen-Chin Lee, Shih-Wei Wang, Chiang-Chi Huang, Yueh-Ting Lee, Chung-Ming Fu, Jin-Bor Chen, and Lung-Chih Li. Denosumab Is Superior to Raloxifene in Lowering Risks of Mortality and Ischemic Stroke in Osteoporotic Women. MDPI AG, 2023.

MLA (9th ed.) Citation

Ting-Chun Liu, et al. Denosumab Is Superior to Raloxifene in Lowering Risks of Mortality and Ischemic Stroke in Osteoporotic Women. MDPI AG, 2023.

Warning: These citations may not always be 100% accurate.